EN
|
LT
| Trade mark | ||
|---|---|---|
| (210) | Application number | 2024 1418 |
| (220) | Date of filing the application | 2021-12-06 |
| (111) | Registration number | 92319 |
| (151) | Registration date | 2024-11-28 |
| (181) | Expire | 2031-12-06 |
| (442) | Date of application publication, bulletin No. | 2024-08-12, 2024/15 |
| (450) | Date of registration publication, bulletin No. | 2024-12-10, 2024/23 |
| Legal status |
Registered
|
|
| Reproduction of the mark | ||
| (540) | VIR BIOTECHNOLOGY | |
| (531) | Indication of Vienna Classification | |
| Indication concerning colors claimed | ||
| (591) | ||
| Indication of International Classification of Goods and Services, list of goods and (or) services | ||
| (511) |
5 vaistai; vaistiniai preparatai, skirti naudoti infekcinėms ligoms ir sutrikimams gydyti, ir onkologijos srityje. |
|
|
42 moksliniai tyrimai ir plėtra farmacijos ir biotechnologijų srityse; farmacinių preparatų ir vaistų tobulinimas. |
||
| Applicant (731) / Owner (732) | ||
| (732) | Name | Vir Biotechnology, Inc. |
| Address | 499 Illinois Street, Suite 500, San Francisco CA 94158 | |
| Country | US | |
| Attorney or representative | ||
| (740) | Name | Aušra Pakėnienė |
| Address | AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius | |
| Country | LT | |
| Disclaimer | ||
| (526) | ||
| Exhibition priority | ||
| (230) | Date, country | |
| Convention priority | ||
| (300) | Convention priority | 97123120 |
| Date | 2021-11-12 | |
| Country | US | |